["{\n\"step_by_step_thinking\": \"The question asks if there is a favorable subset of patients with prostate cancer who develop oligometastases. The relevant documents mention the progression of local tumour to stage T3 in 67 patients (Deferred treatment in clinically localised prostatic carcinoma) and the development of distant metastases in 17 patients (Markers of the metastatic phenotype in prostate cancer). However, there is no specific information on a favorable subset of patients who develop oligometastases. The documents do not provide any insight into the prognosis or outcome of patients with oligometastases.\",\n\"answer_choice\": B"]